Published in Front Immunol on December 12, 2013
Failed CTL/NK cell killing and cytokine hypersecretion are directly linked through prolonged synapse time. J Exp Med (2015) 1.04
Genetic predisposition to hemophagocytic lymphohistiocytosis: Report on 500 patients from the Italian registry. J Allergy Clin Immunol (2015) 0.92
Practical NK cell phenotyping and variability in healthy adults. Immunol Res (2015) 0.81
Whole-Exome Sequencing Reveals Mutations in Genes Linked to Hemophagocytic Lymphohistiocytosis and Macrophage Activation Syndrome in Fatal Cases of H1N1 Influenza. J Infect Dis (2015) 0.78
The In Vivo Granulopoietic Response to Dexamethasone Injection Is Abolished in Perforin-Deficient Mutant Mice and Corrected by Lymphocyte Transfer from Nonsensitized Wild-Type Donors. Mediators Inflamm (2015) 0.76
Melanoma cell lysosome secretory burst neutralizes the CTL-mediated cytotoxicity at the lytic synapse. Nat Commun (2016) 0.76
Molecular mechanisms regulating cytotoxic lymphocyte development and function, and their associations to human diseases. Front Immunol (2014) 0.75
Dynein Separately Partners with NDE1 and Dynactin To Orchestrate T Cell Focused Secretion. J Immunol (2016) 0.75
Missense mutations in the perforin (PRF1) gene as a cause of hereditary cancer predisposition. Oncoimmunology (2016) 0.75
Intravascular large B-cell lymphoma associated with silicone breast implant, HLA-DRB1*11:01, and HLA-DQB1*03:01 manifesting as macrophage activation syndrome and with severe neurological symptoms: a case report. J Med Case Rep (2016) 0.75
Variations of the perforin gene in patients with chronic inflammatory demyelinating polyradiculoneuropathy. Genes Immun (2014) 0.75
Cytokines and metabolic factors regulate tumoricidal T-cell function during cancer immunotherapy. Immunotherapy (2017) 0.75
HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer (2007) 16.96
Munc13-4 is essential for cytolytic granules fusion and is mutated in a form of familial hemophagocytic lymphohistiocytosis (FHL3). Cell (2003) 4.94
Perforin gene defects in familial hemophagocytic lymphohistiocytosis. Science (1999) 4.93
Cytotoxic lymphocytes require granzyme B for the rapid induction of DNA fragmentation and apoptosis in allogeneic target cells. Cell (1994) 4.26
Cytotoxic T lymphocyte granules are secretory lysosomes, containing both perforin and granzymes. J Exp Med (1991) 4.15
Immune function in mice lacking the perforin gene. Proc Natl Acad Sci U S A (1994) 4.06
Perforin-mediated target-cell death and immune homeostasis. Nat Rev Immunol (2006) 3.04
Familial and acquired hemophagocytic lymphohistiocytosis. Annu Rev Med (2012) 2.73
Linkage of familial hemophagocytic lymphohistiocytosis (FHL) type-4 to chromosome 6q24 and identification of mutations in syntaxin 11. Hum Mol Genet (2005) 2.70
Human and mouse granzyme A induce a proinflammatory cytokine response. Immunity (2008) 2.57
Familial hemophagocytic lymphohistiocytosis type 5 (FHL-5) is caused by mutations in Munc18-2 and impaired binding to syntaxin 11. Am J Hum Genet (2009) 2.29
Purification of three cytotoxic lymphocyte granule serine proteases that induce apoptosis through distinct substrate and target cell interactions. J Exp Med (1992) 2.25
The structural basis for membrane binding and pore formation by lymphocyte perforin. Nature (2010) 2.23
Atypical features of familial hemophagocytic lymphohistiocytosis. Blood (2004) 2.21
Munc18-2 deficiency causes familial hemophagocytic lymphohistiocytosis type 5 and impairs cytotoxic granule exocytosis in patient NK cells. J Clin Invest (2009) 2.08
A natural killer cell granule protein that induces DNA fragmentation and apoptosis. J Exp Med (1992) 2.01
The molecular basis for perforin oligomerization and transmembrane pore assembly. Immunity (2009) 1.98
Molecular mechanisms of biogenesis and exocytosis of cytotoxic granules. Nat Rev Immunol (2010) 1.93
Cytotoxicity with target DNA breakdown by rat basophilic leukemia cells expressing both cytolysin and granzyme A. Cell (1992) 1.82
Distinct mutations in STXBP2 are associated with variable clinical presentations in patients with familial hemophagocytic lymphohistiocytosis type 5 (FHL5). Blood (2012) 1.82
Protection from endogenous perforin: glycans and the C terminus regulate exocytic trafficking in cytotoxic lymphocytes. Immunity (2011) 1.73
Perforin polymorphism A91V and susceptibility to B-precursor childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group. Leukemia (2006) 1.57
A proportion of patients with lymphoma may harbor mutations of the perforin gene. Blood (2005) 1.54
Perforin forms transient pores on the target cell plasma membrane to facilitate rapid access of granzymes during killer cell attack. Blood (2013) 1.53
Adult onset and atypical presentation of hemophagocytic lymphohistiocytosis in siblings carrying PRF1 mutations. Blood (2002) 1.49
Hemophagocytosis causes a consumptive anemia of inflammation. J Exp Med (2011) 1.43
Whole-genome sequencing identifies a recurrent functional synonymous mutation in melanoma. Proc Natl Acad Sci U S A (2013) 1.35
Perforin: structure, function, and role in human immunopathology. Immunol Rev (2010) 1.30
Localization of a gene for familial hemophagocytic lymphohistiocytosis at chromosome 9q21.3-22 by homozygosity mapping. Am J Hum Genet (1999) 1.27
A functional analysis of the putative polymorphisms A91V and N252S and 22 missense perforin mutations associated with familial hemophagocytic lymphohistiocytosis. Blood (2005) 1.22
A single amino acid change A91V in perforin: a novel, frequent predisposing factor to childhood acute lymphoblastic leukemia? Haematologica (2005) 1.15
Chronic active Epstein-Barr virus infection associated with mutations in perforin that impair its maturation. Blood (2003) 1.14
Temperature sensitivity of human perforin mutants unmasks subtotal loss of cytotoxicity, delayed FHL, and a predisposition to cancer. Proc Natl Acad Sci U S A (2009) 1.14
A role for granzyme M in TLR4-driven inflammation and endotoxicosis. J Immunol (2010) 1.13
A single amino acid change, A91V, leads to conformational changes that can impair processing to the active form of perforin. Blood (2005) 1.12
Functional dissection of the granzyme family: cell death and inflammation. Immunol Rev (2010) 1.12
Perforin activity and immune homeostasis: the common A91V polymorphism in perforin results in both presynaptic and postsynaptic defects in function. Blood (2007) 1.10
Rapid and unidirectional perforin pore delivery at the cytotoxic immune synapse. J Immunol (2013) 1.08
A91V is a polymorphism in the perforin gene not causative of an FHLH phenotype. Blood (2004) 1.06
The functional basis for hemophagocytic lymphohistiocytosis in a patient with co-inherited missense mutations in the perforin (PFN1) gene. J Exp Med (2004) 1.05
Genotype-phenotype study of familial haemophagocytic lymphohistiocytosis type 3. J Med Genet (2011) 1.05
Variations of the perforin gene in patients with multiple sclerosis. Genes Immun (2008) 0.96
Germline mutations of the perforin gene are a frequent occurrence in childhood anaplastic large cell lymphoma. Cancer (2007) 0.96
A triple-mutated allele of granzyme B incapable of inducing apoptosis. Proc Natl Acad Sci U S A (2003) 0.91
Human perforin mutations and susceptibility to multiple primary cancers. Oncoimmunology (2013) 0.90
A teenage boy with late onset hemophagocytic lymphohistiocytosis with predominant neurologic disease and perforin deficiency. Pediatr Blood Cancer (2008) 0.89
Novel mutation of the perforin gene and maternal uniparental disomy 10 in a patient with familial hemophagocytic lymphohistiocytosis. J Pediatr Hematol Oncol (2008) 0.86
Variations of the perforin gene in patients with type 1 diabetes. Diabetes (2008) 0.86
Development of classical Hodgkin's lymphoma in an adult with biallelic STXBP2 mutations. Haematologica (2012) 0.81
Human granzyme B is essential for DNA fragmentation of susceptible target cells. Eur J Immunol (1994) 0.80
The granzyme B gene is highly polymorphic in wild mice but essentially invariant in common inbred laboratory strains. Tissue Antigens (2007) 0.79
Fatal immune dysregulation due to a gain of glycosylation mutation in lymphocyte perforin. Blood (2011) 0.78